1.07 Adjuvant Sunitinib in RCC, future of EBM with Dr. John Mandrola
In this episode we discuss the USA FDA's recent a…
Plenary Session - inactive due to federal service · Plenary Session - inactive due to federal service
September 11, 20181h 2mExplicit
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode we discuss the USA FDA's recent approval of sunitinib as the adjuvant treatment for patients with resected renal cell carcinoma who are at high risk of relapse. We also interview cardiologist Dr. John Mandrola on new directions forward for evidence-based medicine.
Topics
medicineoncologyhealthpolicy